首页 | 本学科首页   官方微博 | 高级检索  
检索        

醒脑静滴鼻液中栀子苷的家兔体内药动学研究
引用本文:姚宗玲,陆洋,杜守颖,陈晓兰,王玥.醒脑静滴鼻液中栀子苷的家兔体内药动学研究[J].中国中药杂志,2010,35(14):1871-1873.
作者姓名:姚宗玲  陆洋  杜守颖  陈晓兰  王玥
作者单位:北京中医药大学,中药学院,北京,100102
基金项目:国家"重大新药创制"科技重大专项(2009ZX09502-008)
摘    要:目的:建立测定家兔血浆中栀子苷浓度的高效液相方法,研究醒脑静滴鼻液鼻腔给药后栀子苷在家兔体内的药动学过程。方法:醒脑静滴鼻液家兔鼻腔给药,给药量为12 mg.kg-1(以栀子提取物计),于给药后1,3,5,10,20,30,45,60,90,120,240 min左颈动脉采血,乙腈沉淀法处理血浆样品,HPLC测定血浆中栀子苷浓度,以Kinetica软件拟合药动学参数。结果:血浆中栀子苷在0.136 5~2.73 mg.L-1线性良好,相关系数为0.999 6,低、中、高浓度回收率分别为(97.14±3.78)%,(95.06±2.95)%,(91.50±1.82)%,其日内、日间精密度RSD均小于4%,符合要求。醒脑静滴鼻液鼻腔给药后,栀子苷家兔血浆药动学过程符合二室开放模型,主要药动学参数(拟合值)为Cmax为(2.013±0.563)mg.L-1,Tmax为(6.405±1.764)min,Ke为(0.032 5±0.013 3)min-1,CL为(0.059 3±0.024 6)L.min-1.kg-1,AUC为(116.89±50.19)mg.min-1.L-1,MRT为(84.447±19.420)min。结论:本实验中建立的血浆处理及HPLC方法适用于家兔体内栀子苷的含量测定和药代动力学研究,醒脑静鼻腔给药后栀子苷吸收迅速,具有较好的应用前景。

关 键 词:醒脑静  栀子苷  鼻腔给药  血药浓度  二室模型
收稿时间:2009/10/20 0:00:00

Study on pharmacokinetics of jasminoidin in rabbits administered Xingnaojing naristillae by nasal medication
YAO Zongling,LU Yang,DU Shouying,CHEN Xiaolan and WANG Yue.Study on pharmacokinetics of jasminoidin in rabbits administered Xingnaojing naristillae by nasal medication[J].China Journal of Chinese Materia Medica,2010,35(14):1871-1873.
Authors:YAO Zongling  LU Yang  DU Shouying  CHEN Xiaolan and WANG Yue
Institution:School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China;School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China;School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China;School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China;School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China
Abstract:Objective : To develop an HPLC method for the determination of plasma concentration of jasminoidin and study the pharmacokinetics of jasminoidin in rabbits administered Xingnaojing naristillae by nasal medication. Method : After sampling blood from the left arteria carotis of rabbits which were administered Xingnaojing naristillae medication by nasal by 12 mg·kg-1 (counted by gardenia extract) at 1, 3, 5, 10, 20, 30, 45, 60, 90, 120, 240 min, the plasma samples were dealt with acetonitrile precipitation and HPLC was used to determine the plasma concentration of jasminoidin. The pharmacokinetic parameters were computed by Kinetica software. Result : The calibration curve was linear (r=0.999 6) within the range of 0.136 5-2.73 mg·L-1 for jasminoidin in plasma. The average recovery was (97.14±3.78)%, (95.06±2.95)%, (91.50±1.82)%. The within-day and between-day precision met the requirements,because the RSD were both less than 4%. Jasminoidin was fitted to a two-compartment open pharmacokinetic model in rabbits. The mainly pharmacokinetic parameters were: Cmax=(2.013±0.563) mg·L-1, Tmax =(6.405±1.764) min, Ke=(0.032 5±0.013 3) min-1, CL=(0.059 3±0.024 6) L·min-1 · kg-1, AUC =(116.89±50.19) mg·min-1·L-1, MRT=(84.447±19.420) min. Conclusion : The method can be used to determine the concentration and to investigate the pharmacokinetics of jasminoidin in rabbits. Jasminoidin was absorbed rapidly by nasal medication and has a good perspective.
Keywords:Xingnaojing  jasminoidin  nasal administration  plasma concentration  two-compartment model
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号